8 completed, 2 unknown, 1 terminated. 2 Not applicable, 2 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Acinetobacter Infections: new trials by email Literature Review of Acinetobacter Infections trials Research Report on Acinetobacter Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection Colistin, Minocycline, Placebo - Acinetobacter Infections | Phase 4 | Unknown | Mahidol University | 94 | 2023-01-10 | 2023-01-18 |
| Clinical Outcomes in Patients With Infection by Resistant Microorganism Pathogen resistant phenotype - Pneumonia, Bloodstream Infection | Unknown | Hospital Universitario Virgen Macarena | 5000 | 2022-10-01 | 2023-05-30 | |
| Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections Duration of therapy - Carbapenem-Resistant Enterobacteriaceae Infection, Bloodstream Infection | Not applicable | Terminated | Hospital Moinhos de Vento | 107 | 2022-01-27 | 2024-03-06 |
| Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers TP-102 - Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection | Phase 1 / Phase 2 | Completed | Technophage, SA | 20 | 2021-03-22 | 2022-10-04 |
| Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii colistin and rifampin combination therapy, colistin monotherapy - Colistin, Rifampin | Not applicable | Completed | Gangnam Severance Hospital | 9 | 2016-10-27 | 2018-08-09 |
| Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection colistimethate sodium - Acinetobacter Infections | Completed | DongGuk University | 30 | 2015-05-01 | 2018-06-26 | |
| Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections Sulbactam - Acinetobacter Infections | Phase 4 | Completed | Sutep Jaruratanasirikul | 18 | 2014-09-01 | 2017-09-20 |
| Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical Colistin, Tigecycline, Vancomycin - Acinetobacter Infections | Completed | Maimónides Biomedical Research Institute of Córdoba | 113 | 2010-01-01 | 2015-10-09 | |
| Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol Acinetobacter Infections | Completed | University of Pittsburgh | 100 | 2009-04-01 | 2018-06-14 | |
| Clinical Outcomes and Global Epidemiology -Data Coordinating Center Acinetobacter Infections | Completed | University of Pittsburgh | 400 | 2007-07-01 | 2018-06-12 | |
| Risk Factors for Carbapenem-resistant Acinetobacter Baumannii Acinetobacter Infections | Completed | University of Pittsburgh | 100 | 2007-04-01 | 2018-06-12 |
Pseudomonas Infections (3) · Sepsis (3) · Infections (2) · Staphylococcal Infections (2) · Bacteremia (1) · Cellulitis (1) · Diabetic Foot (1) · Escherichia coli Infections (1) · Gram-Negative Bacterial Infections (1) · Pneumonia (1) · Surgical Wound Infection (1) · Urinary Tract Infections (1) · cyclopia sequence (1)
Bacterial Infections (11) · Bacterial Infections and Mycoses (11) · Moraxellaceae Infections (11) · Gram-Negative Bacterial Infections (10) · Infections (9) · Inflammation (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Systemic Inflammatory Response Syndrome (3) · Gram-Positive Bacterial Infections (2) · Skin and Connective Tissue Diseases (2) · Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1)
Colistin (4) · colistinmethanesulfonic acid (2) · Duration of Therapy (1) · Minocycline (1) · Sulbactam (1) · Tigecycline (1) · Vancomycin (1)
University of Pittsburgh (3) · DongGuk University (1) · Gangnam Severance Hospital (1) · Hospital Moinhos de Vento (1) · Hospital Universitario Virgen Macarena (1) · Mahidol University (1) · Maimónides Biomedical Research Institute of Córdoba (1) · Sutep Jaruratanasirikul (1) · Technophage, SA (1)
United States (3) · Thailand (2) · Brazil (1) · Israel (1) · South Korea (1) · Spain (1)
David Paterson, MD (2) · Adhiratha Boonyasiri, MD (1) · Alexandre Prehn Zavascki (1) · David L Paterson, MD (1) · Ran Nir-Paz, MD (1) · Ronen Ben Ami, MD (1) · Young-Soon Yoon, professor (1)
PMID 28970161, PMID 30476654, PMID 34775134, PMID 38102448, PMID 39695798, PMID 39740667